You have no items in your shopping cart.
Search results for: 'TNF-α'
- RecombinantTNF-α,Human [orb1494766]
> 98% as analyzed by SDS-PAGE and HPLC.
17.3 kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 10 μg, 50 μg > 95% by SDS-PAGE analysis.
18.3kDa, observed by reducing SDS-PAGE.
Escherichia coli.
1 mg, 10 μg, 50 μg- RecombinantTNF-α,Bovine [orb1494769]
> 95% as analyzed by SDS-PAGE & HPLC
17.6 kDa, observed by reducing SDS-PAGE
Escherichia coli.
10 μg, 1 mg, 50 μg > 95% as analyzed by SDS-PAGE.
14-30 kDa, observed by reducing SDS-PAGE.
CHO
10 μg, 50 μg> 98% as analyzed by SDS-PAGE.
8.7 kDa, observed by reducing SDS-PAGE.
HEK 293
5 μg, 25 μg, 1 mg>95% by SDS-PAGE and HPLC analyses.
Approximately 17.5 kDa. The recombinant protein preparation is a mixture of a 158 amino acid residue form containing an N-terminal methionine and a 157 amino acid residue form with the sequence of mature human TNF-α.
Escherichia coli.
10 μg, 50 μg, 1 mg>95% by SDS-PAGE and HPLC analyses.
Approximately 17.5 kDa. a single, non-glycosylated, polypeptide chain containing 157 amino acids fragment (77-233) and having a molecular mass of 21.85 kDa with an amino-terminal hexahistidine tag.
Escherichia coli.
10 μg, 50 μg, 1 mgELISA, WB
Human
Mouse, Rat
Rabbit
Polyclonal
Unconjugated
100 μg- TNF-α polyclonal antibody [orb1717321]
IF, IHC, WB
Human, Mouse, Rat
Rabbit
Polyclonal
Unconjugated
50 μl, 100 μl

